INTRODUCTION
An important question in clinical oncology is to understand the biochemical basis for the onset of resistance to anticancer drugs such as adriamycin and vinblastin, which are derived from natural products. Multidrug resistance (MDR) arises when cells selected for resistance to a single drug develop cross-resistance to other chemotherapeutic drugs [1, 2] . A common feature of the MDR phenotype is the overexpression of a membrane-associated P-glycoprotein which appears to function as a drug-efflux pump to decrease the intracellular accumulation of drugs [3, 4] . In addition to overexpression of P-glycoprotein, other mechanisms also have been implicated to modulate MDR, including changes in transmembrane signalling pathways. Protein kinase C (PKC) activity has been shown to be elevated in a number of drugresistant cell types [5] [6] [7] [8] . Other studies have shown that treatment of MDR cells with agents which alter PKC activity also altered the drug-resistant phenotype [5, 6, 9, 10] , further suggesting a role for PKC in multidrug resistance.
Since PKC is regulated by diacylglycerol generated in response to stimulation of various phospholipase activities, changes in phospholipase activities also might be expected in MDR cells. In addition, other observations also suggest that phospholipase activities may be changed in multidrug resistance. Physical changes in membrane structure, a consequence of altered phospholipid composition, have been linked to alterations in the sensitivity of cells to the cytotoxic effects of anticancer drugs [11] [12] [13] [14] [15] . Further, it has been suggested that phosphatidylethanolamine (PtdEtn) can activate the ATPase activity of the P-glycoprotein transporter [16] . These findings suggested that it would be of interest to extend our investigations of the biological and regulatory properties of phospholipases to drug-sensitive (MCF-7/WT) and multidrug-resistant (MCF-7/MDR) human breast carcinoma cells.
PtdEtn (-29-fold), but had no effect on the hydrolysis of PtdCho. The PLD activators sphingosine and H202 were found to elicit only a slight (1.28-1.4-fold) stimulatory effect on PtdCho hydrolysis in both the MCF-7/WT and MCF-7/MDR cell types, and had only a small effect on PtdEtn hydrolysis in the MCF-7/WT cells as well. However, these agents significantly (-2.6-3. -fold) stimulated PtdEtn hydrolysis in the MCF-7/ MDR cells. These data indicate that MCF-7/MDR cells contain a PtdEtn-specific PLD activity which can be selectively stimulated by PMA, sphingosine and H202* The hydrolysis of phospholipids by hormone-and phorbol ester-stimulated phospholipase D (PLD) results in the formation of phosphatidic acid [17, 18] . Phosphatidic acid can serve as a messenger molecule with the potential to regulate cell growth [19] [20] [21] [22] [23] [24] , exocytosis [25] [26] [27] [28] [29] [30] , as well as other cellular processes (reviewed in [31] ). In view of the emerging role of PLD in signal transduction, it is important to characterize the regulatory properties of PLD and to identify the phospholipid pools which can serve as substrates. There is agreement that activators of PKC, in addition to GTP, ATP and various growth-regulatory molecules, are prominent regulators of PLD [17, 18, 31] . With regard to substrate specificity, a number of laboratories have reported only the hydrolysis of phosphatidylcholine (PtdCho) by activated PLD, although in many cases this was the only phospholipid examined [17, 18] . In a more recent study with microsomal PLD, Horwitz and Davis [32] also observed that PtdCho appeared to be the substrate of PLD, although they did note some hydrolysis of PtdEtn.
In contrast, we have noted that activation of PLD in NIH 3T3 fibroblasts by the PKC activator phorbol 12-myristate 13-acetate (PMA) [33, 34] , ATP [35] , GTP [35] , sphingosine [35, 36] , staurosporine [36] , H202 [37] or hormones [38] led to comparable hydrolysis of both PtdCho and PtdEtn. Recently, stimulation of PtdEtn hydrolysis in response to activators of PLD also has been reported in several other cell types [39] [40] [41] [42] [43] [44] [45] [46] 12 mg/ml L-proline, 50 ,ug/ml gentamicin and 10 % fetal bovine serum. Cells were passaged twice weekly and monitored routinely for their resistance to adriamycin. The MCF-7/MDR cells were periodically reselected by growing them in the presence of increasing concentrations of adriamycin (up to 10,uM) for a period of approx. 2 months.
Measurement of formation of PtdEtOH In MCF-7 cells
MCF-7 cells were grown in 6-well tissue-culture dishes for 48 h to about 80 % confluency, and labelled with [1-"4C]palmitic acid (0.35 mCi/ml) for the last 24 h. Cells were washed, incubated in fresh IMEM for an additional 2 h (to minimize the amount of unesterified labelled palmitic acid), and then treated with PMA in the presence of 200 mM ethanol for 30 min. Incubations were performed in an incubator at 37°C and were terminated by scraping the cells into 2 ml of ice-cold methanol, followed by rapid transfer of the methanol extract to 2 ml of chloroform. PtdEtOH was separated from other phospholipids on potassium oxalate (1 %)-impregnated silica gel H plates (Analtech) with a solvent system of chloroform/methanol/acetone/acetic acid/water (50:10:15:10:2, by vol.).
Measurement of PLD-mediated hydrolysis of PtdCho and PtdEtn
In MCF-7 cells MCF-7 cells were grown in 6-well tissue-culture dishes for 48 h (up to 80% confluency) in the presence of [14C]choline (0.6 mCi/ml) or [14C]ethanolamine (0.4 mCi/ml). Cells were washed and incubated in fresh IMEM for 3 h, followed by treatments with PMA as described in Figure 2 in the presence of 20 mM choline or 2 mM ethanolamine, as appropriate. Incuba [47] . The initial flow-through (4.5 ml), along with a following 3.5 ml or 5 ml water wash, contained glycerophosphoethanolamine or glycerophosphocholine, respectively. Ethanolamine phosphate and choline phosphate were then eluted by 15 ml and 20 ml of water, respectively. Finally, ethanolamine and choline were eluted by 12 ml and 20 [33] . Phospholipids were separated as described previously [48] .
In some experiments, cells were grown in 150 mm-diameter dishes in the presence of either [methyl-14C]choline (0.3 mCi/ml) or [2-14C] [38] and [49] ). Scraped cells were collected by centrifugation ( 
RESULTS
Comparison of effects of PMA on PtdEtOH synthesis In MCF-7/WT and MCF-7/MDR cells PLD is uniquely capable of synthesizing phosphatidylalcohol from phospholipid acceptors and alcohol [17, 18] . Since production of phosphatidylalcohol appears to be a reliable measure of PLD activity, we determined the effect of PMA on PtdEtOH formation in the drug-sensitive and drug-resistant MCF-7 cell lines. In the presence of serum (but not in its absence), MCF-7/WT cells synthesized a small amount of PtdEtOH, which was somewhat inhibited, rather than enhanced, by increasing concentrations of PMA (Figure 1 ). In contrast, in MCF-7/MDR cells PMA greatly enhanced PtdEtOH formation; near halfmaximal (-9-fold) and maximal (-21-fold) stimulatory effects were observed with 10 and 100 nM concentrations of PMA respectively (Figure 1 [33, 38, 49] . As shown in Figure   2 [35, 36, 50] and H202 [46] , which appear to stimulate phospholipid hydrolysis through PKC-independent mechanisms. Each compound was used at a maximally effective concentration for an optimal period of incubation (20 min), as determined in preliminary experiments. As shown in Table 1 , sphingosine and H202 stimulated the hydrolysis of both PtdCho and PtdEtn hydrolysis in both the drug-sensitive and drugresistant MCF-7 cell types. However, the stimulatory effects of these compounds on PtdCho hydrolysis in the MCF-7/WT and MCF-7/MDR cells, as well as on PtdEtn hydrolysis in the MCF-7/WT line, were relatively (1.28-1.4-fold) small. In contrast, treatment of MCF-7/MDR cells with H202 and sphingosine stimulated PtdEtn hydrolysis by 2.56-and 3.5-fold, respectively (Table 1 ). In agreement with data in Figures 2 and 3 , PMA enhanced only PtdEtn hydrolysis, and only in the MCF-7/MDR line (Table 1) . Previously, we reported that in NIH 3T3 fibroblasts PMA and sphingosine additively or synergistically (depending on the length of incubation) enhanced PtdEtn hydrolysis [36] . As presented in Table 1 , in the drug-resistant cells PMA and sphingosine stimulated PtdEtn hydrolysis about 4.5-and 3.5-fold, respectively, whereas in combination they had a 9.1-fold stimulatory effect. In comparison, in the drug-sensitive cells PtdEtn hydrolysis was stimulated only 1.4-fold by PMA plus sphingosine ( Table 1) .
Formation of glycerophospho gIycerophosphoethanolamine choline and
In MCF-7/WT cells A somewhat controversial finding in these studies was that MCF-7/WT cells produced relatively large amounts of choline and ethanolamine from the respective labelled phospholipids (Figures 2 and 3) , even though the PLD activity in these cells appeared to be relatively low (Figure 1) . Therefore, it was considered that a significant portion of the production of choline and ethanolamine in the unstimulated cells could involve non-PLD-mediated mechanisms. If so, a possible mechanism might be that degradation of phospholipids by type A phospholipases would occur at higher rates in the drug-sensitive than in the drug- [51] , that PtdEtn and PtdCho may be hydrolysed by different PLD activities. Thus, it might be expected that the relative levels of these PLD activities might differ in various cell types. Based on the measured rate of PtdCho and PtdEtn hydrolysis, a number of cell types examined appear to possess only the PtdCho-specific PLD activity (reviewed in [17, 18] ). On the other hand, NIH 3T3 fibroblasts [33] [34] [35] [36] [37] [38] , endothelial cells [46] , rat mesangial cells [41] [42] [43] [44] , human amnion cells [45] , rat mammary cells [40] , HeLa cells [39] , baby-hamster kidney cells [33] and HL60 human leukaemic cells [33] clearly express both PtdCho-and PtdEtn-hydrolysing PLD activities.
Although PMA failed to stimulate PtdCho hydrolysis in these MCF-7 lines, a low level of PtdCho-specific PLD activity appears to be present both in the drug-sensitive and drug-resistant cells, based on the low levels of stimulation noted with H202 and sphingosine. The reason why this residual PtdCho-PLD activity was not enhanced by PMA is not clear. One possibility is that mammalian cells may contain several isoforms of PtdCho-PLD, each of which exhibiting different regulatory properties. The form of PtdCho-hydrolysing PLD present in MCF-7 cells may respond to sphingosine and H202, but not to PKC activators such as PMA. Another possibility is that the effect of PMA on PtdCho-specific PLD, unlike that of sphingosine and H202, may require an intermediate step which is impaired in the MCF-7 cells. Alternatively, the levels of a PKC isoenzyme or a possible intermediate PKC substrate, which may serve to mediate the effects of PMA on the hydrolysis of PtdEtn and PtdCho, could be altered in these cells. Previous studies have established that the PKC isoenzyme pattern is altered in these cells, with the PKC-a isoform being markedly elevated in MCF-7/MDR cells [52] . In either case, the observations that PMA, sphingosine and H202 each had significant stimulatory effects only on PtdEtn hydrolysis, and only in MCF-7 cells exhibiting the drug-resistant phenotype, suggests that stimulation of PtdEtn hydrolysis by these agents involves a common PLD enzyme which is different from the PtdCho-hydrolysing PLD activity.
The finding that the PtdEtn-hydrolysing system is independently regulated by the PKC system also suggests that PtdEtn hydrolysis may have a physiological function different from that of PtdCho hydrolysis. Since increased PtdEtn hydrolysis specifically occurs in the drug-resistant cells, it is possible that increased PtdEtn hydrolysis contributes, together with other factors, to the modulation of increased drug efflux and/or decreased drug influx. In light of the known fusogenic property of phosphatidic acid, it is possible that the PLD-mediated formation of this phospholipid from PtdEtn might stimulate drug efflux by facilitating the interaction between drug-accumulating intramembrane vesicles and plasma membrane [53] [54] [55] [56] . Another possibility is that alterations in the plasma-membrane levels of PtdEtn and phosphatidic acid result in alterations in membrane structure which influence the activity of the transmembrane P-glycoprotein transporters. In this regard, PtdEtn recently has been reported to activate P-glycoprotein ATPase activity [16] . If there is indeed a correlation between MDR and PMA-sensitive PtdEtn-specific PLD, then a similar pattern ofPLD activation should be observed in any independently cloned resistant lines of breast carcinoma cells. This latter possibility is at present under investigation in
